NASDAQ:ARCT

Arcturus Therapeutics Holdings Stock Forecast

etoro logo Buy ARCT
*Your capital is at risk
$6.39
+0.0200 (+0.314%)
At Close: Jul 15, 2026
AI Analysis AI Analysis of ARCT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ARCT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Arcturus Therapeutics Holdings Inc. stock price up 0.314% on Wednesday
(Updated on Jul 15, 2026)

Sell candidate since Jul 09, 2026 Loss -10.75%

The Arcturus Therapeutics Holdings Inc. stock price gained 0.314% on the last trading day (Wednesday, 15th Jul 2026), rising from $6.37 to $6.39. During the last trading day the stock fluctuated 4.46% from a day low at $6.28 to a day high of $6.56. The price has been going up and down for this period, and there has been a -4.91% loss for the last 2 weeks. Volume fell on the last day by -277 thousand shares and in total, 371 thousand shares were bought and sold for approximately $2.37 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.33 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -22.32% during the next 3 months and, with a 90% probability hold a price between $4.92 and $5.91 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ARCT Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 0.314%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcturus Therapeutics Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.93 and $7.20. A break-up above any of these levels will issue buy signals.

Support, Risk & Stop-loss for Arcturus Therapeutics Holdings Inc. stock

Arcturus Therapeutics Holdings Inc. finds support from accumulated volume at $6.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.280 between high and low, or 4.46%. For the last week, the stock has had daily average volatility of 6.89%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARCT) For The Upcoming Trading Day Of Thursday 16th

For the upcoming trading day on Thursday, 16th we expect Arcturus Therapeutics Holdings Inc. to open at $6.41, and during the day (based on 14 day Average True Range), to move between $6.15 and $6.63, which gives a possible trading interval of +/-$0.477 (+/-7.75%) up or down from last closing price. If Arcturus Therapeutics Holdings Inc. takes out the full calculated possible swing range there will be an estimated 7.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.37 (0.31%) than the resistance at $6.82 (6.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Arcturus Therapeutics Holdings Inc. stock A Buy?

Arcturus Therapeutics Holdings Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.783 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 16, 2026 - $6.41 ( 0.313%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ARCT Performance

Trading levels for ARCT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.69 4.69%
R2 6.58 3.02%
R1 6.52 1.99%
Price 6.39
S1 6.30 -1.36%
S2 6.24 -2.39%
S3 6.13 -4.07%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.28 13.93%
R2 7.16 12.05%
R1 6.82 6.73%
Price 6.39
S1 6.37 -0.313%
S2 0 -
S3 0 -

ARCT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 27, 2012 Jan 08, 2013 Jan 15, 2013 $0.0596 0%
2 Dec 28, 2012 Jan 04, 2013 Jan 15, 2013 $0.0596 0%
3 Nov 28, 2012 Dec 05, 2012 Dec 15, 2012 $0.0600 0%
4 Oct 26, 2012 Nov 06, 2012 Nov 15, 2012 $0.0600 0%
5 Sep 27, 2012 Oct 03, 2012 Oct 15, 2012 $0.0600 0%

FAQ

What is the symbol for Arcturus Therapeutics Holdings Inc. Stock and on which exchange is it traded?
The symbol for Arcturus Therapeutics Holdings Inc. is ARCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcturus Therapeutics Holdings Inc. Stock?
Arcturus Therapeutics Holdings Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Arcturus Therapeutics Holdings Inc. Stock?
Arcturus Therapeutics Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcturus Therapeutics Holdings Inc. Stock.

What's the current price of Arcturus Therapeutics Holdings Inc. Stock?
As of the end of day on the Jul 15, 2026, the price of an Arcturus Therapeutics Holdings Inc. (ARCT) share was $6.39.

What is the 52-week high and low for Arcturus Therapeutics Holdings Inc. Stock?
The 52-week high for Arcturus Therapeutics Holdings Inc. Stock is $24.08 and the 52-week low is $5.85.

What is the market capitalization of Arcturus Therapeutics Holdings Inc. Stock?
As of the Jul 15, 2026, the market capitalization of Arcturus Therapeutics Holdings Inc. is 181.623M.

When is the next earnings date for Arcturus Therapeutics Holdings Inc.?
The upcoming earnings date for Arcturus Therapeutics Holdings Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT ARCTURUS THERAPEUTICS HOLDINGS INC.
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as we...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
4.04% Jul 13
SRPT
$17.02
3.47% Jun 29
NMRK
$15.02
3.26% Jun 24
JLL
$299.78
9.38% Jun 24
CAG
$13.43
4.94% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE